Tears in bioprosthetic heart valve leaflets without calcific degeneration

被引:0
|
作者
Haziza, F
Papouin, G
BarrattBoyes, B
Christie, G
Whitlock, R
机构
[1] CTR HOSP TERR POLYNESIE FRANCAISE, DEPT CARDIOL, PAPEETE, FRANCE
[2] GREEN LANE HOSP, DEPT CARDIOTHORAC SURG & BIOMED STAT, AUCKLAND, NEW ZEALAND
[3] SYSTEMAT SOLUT LTD, AUCKLAND, NEW ZEALAND
来源
JOURNAL OF HEART VALVE DISEASE | 1996年 / 5卷 / 01期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim of the study: The mechanism of structural failure of bioprosthetic valves is still not clearly understood. This study was undertaken to assess pure leaflet tear as a mode of failure in porcine and pericardial bioprostheses. Methods: Of 246 bioprosthetic valves (109 porcine, 137 pericardial) implanted between 1975 and 1991, 101 had to be explanted and served as the study population. Results: The reasons for valve failure were calcific degeneration in 73, pure tear in 12, and endocarditis in 10. Six other patients had a perivalvar leak. The mean age at operation was 32 years. Freedom from degeneration at 10 years was 45 +/- 7% and from pure tear it was 92 +/- 2% The hazard functions were strikingly different, as that for degeneration showed a progressive increase while that for pure tear peaked at six years post-implant. The mean age of the patients with pure tear was 41 years and for degeneration it was 24 years (p=0.00001). The reasons for the difference in hazard function are discussed. The characteristic clinical features of pure tear allow clinical diagnosis in the majority of patients. Conclusion: Pure tear is the result of uneven tissue loading with tearing occurring at sites of maximal stress. The four possible mechanisms in pericardial valves are (a) intense stress concentration at the top of the stent post (commissure); (b) compression stress below the top of the post; (c) abrasion stress in tissue mounted outside the frame; and (d) increased bending stresses on leaflet opening. In stent-mounted porcine valves, pure tear is related to incorrect mounting or to increased bending stresses.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 50 条
  • [41] Bioprosthetic heart valve structural degeneration associated with metabolic syndrome: Mitigation with polyoxazoline modification
    Abramov, Alexey
    Xue, Yingfei
    Zakharchenko, Andrey
    Kurade, Mangesh
    Soni, Rajesh K.
    Levy, Robert J.
    Ferrari, Giovanni
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 120 (01)
  • [42] Transcaval Valve-in-Valve-in-Valve Aortic Valve Replacement for Bioprosthetic Valve Degeneration
    Watkins, A. Claire
    Devireddy, Chandan M.
    Al-Atassi, Talal
    Simone, Amy E.
    Forcillo, Jessica
    Thourani, Vinod H.
    INNOVATIONS-TECHNOLOGY AND TECHNIQUES IN CARDIOTHORACIC AND VASCULAR SURGERY, 2018, 13 (02) : 132 - 135
  • [43] Scanning electron microscopic surface topography of ablation catheter perforations and calcific tear in an explanted bioprosthetic heart valve
    Narine, K
    Van Belleghem, Y
    Van Nooten, G
    Taeymans, Y
    ULTRASTRUCTURAL PATHOLOGY, 2005, 29 (01) : 9 - 17
  • [44] Mechanisms of bioprosthetic heart valve calcification
    Brockbank, KGM
    Song, YC
    TRANSPLANTATION, 2003, 75 (08) : 1133 - 1135
  • [45] A reappraisal of bioprosthetic aortic valve failure related to structural valve degeneration
    Le Tourneau, T.
    Cueff, C.
    Guerma, L.
    Guimbretiere, G.
    Piriou, N.
    Warin-Fresse, K.
    Capoulade, R.
    Serfaty, J. M.
    Veziers, J.
    Senage, T.
    Roussel, J. C.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2297 - 2297
  • [46] Paediatric nanofibrous bioprosthetic heart valve
    Namdari, Mehrdad
    Negahdari, Babak
    Eatemadi, Ali
    IET NANOBIOTECHNOLOGY, 2017, 11 (05) : 493 - 500
  • [48] Statin therapy does not affect bioprosthetic valve degeneration
    Rosenhek, R
    Rader, F
    Heger, M
    Gabriel, H
    Binder, T
    Maurer, G
    Baumgartner, H
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 433A - 434A
  • [49] HYPERCHOLESTEROLEMIA IS ASSOCIATED WITH INCREASED INCIDENCE OF BIOPROSTHETIC VALVE DEGENERATION
    Mahjoub, H.
    Mathieu, P.
    Senechal, M.
    Larose, E.
    Dumesnll, J.
    Despres, J.
    Plbarot, P.
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (05) : S309 - S309
  • [50] Pyridoxamine (vitamin B6) Mitigation Of Structural Valve Degeneration Of Bioprosthetic Heart Valves
    Zakharchenko, Andrey
    Thomas, Tina
    Hall, Emily
    Chorny, Michael
    Ferrari, Giovanni
    Levy, Robert
    CIRCULATION, 2023, 148